• Skip to main content
  • Skip to primary sidebar
  • Home
  • News
  • Education
  • Events
  • Interviews
    • Career spotlight
  • Opinion
    • Professional Dilemmas
    • Patient perspective
  • PIPcast
  • Jobs
  • Business Directory

Pharmacy in Practice

EDX/20/1154
Date of prep: December 2020

Prescribing information and
adverse events reporting

For healthcare professionals only

£93 million to accelerate vaccine manufacturing and innovation

18th May 2020 by PIP editor Leave a Comment

 

The race to manufacture millions of doses of a coronavirus vaccine has been boosted with a multi-million-pound government investment, Business Secretary Alok Sharma has announced.

 

The government will invest up to £93 million to accelerate construction of the new Vaccines Manufacturing and Innovation Centre (VMIC) which, when completed, will have capacity to produce enough vaccine doses to serve the entire UK population in as little as six months. The funding will ensure the centre opens in Summer 2021, a full 12 months ahead of schedule.

 

The new Centre, which is already under construction, is a key component of the government’s coronavirus vaccine programme – ensuring that once a vaccine is available it can be produced quickly and in mass quantities.

 

To be located on the Harwell Science and Innovation Campus in Oxfordshire, the new Centre will be the UK’s first not-for-profit organisation established to develop and advance the mass production of vaccines. This will boost the UK’s long-term capacity against future viruses. The centre will also accelerate the production of vaccines for existing illnesses such as the flu virus.

 

While the Centre is being built, the government will establish a rapid deployment facility thanks to a further investment of £38 million to begin manufacturing at scale from Summer 2020. This facility will support efforts to ensure a vaccine is widely available to the public as soon as possible.

 

Business Secretary Alok Sharma said:

 

“As the biggest contributor to the international coalition to find a vaccine, the UK is leading the global response. Once a breakthrough is made, we need to be ready to manufacture a vaccine by the millions.

 

“The new Vaccine Manufacturing and Innovation Centre and temporary facility will build ‘fill and finish’ capacity, bringing the UK vaccine programme together from discovery to distribution.”

 

The Vaccines Manufacturing and Innovation Centre’s Chief Executive Dr Matthew Duchars said:

 

“Today’s announcement by the Business Secretary is an important endorsement for the work the Vaccine Manufacturing and Innovation Centre will deliver in shoring up future domestic supply of vaccines in response to a pandemic.

 

“This investment will rapidly accelerate the construction of the facility, enabling us to bring it online a year sooner. In addition, the capacity will be significantly increased, so that enough vaccines could be made for everyone in the UK within a matter of months of opening.”

 

UK Research and Innovation Chef Executive Sir Mark Walport, said:

 

“The Vaccines Manufacturing and Innovation Centre is an essential new weapon in the UK’s arsenal against diseases and other biological threats, ensuring sufficient vaccines get to the public in the fastest possible time.

 

“The UKRI-funded teams at the University of Oxford and Imperial College London have developed potential coronavirus vaccines at unprecedented speed. By working with partners including government, VMIC and the Vaccines Taskforce to fast-track the manufacturing capability, we are ensuring that momentum will continue all the way from lab to patient.”

 

 

This circular is being shared under the Open Government Copyright licence.

 

Share this:

  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to email this to a friend (Opens in new window)

Related

Next article  Covid-19 community pharmacy vaccine campaign begins

Filed Under: News Tagged With: Vaccine

Register for our upcoming webinar and live Q&A

About PIP editor

Pharmacy in Practice is a UK pharmacy publication with its roots in Scotland.

Reader Interactions

Begin the discussion right here Cancel reply

Primary Sidebar

Categories

Follow Us

  • Twitter
  • LinkedIn
  • Facebook
  • Instagram
  • Twitter

PIP business directory

Letters to the editor

Letters to the editor

Is there a pragmatic way through the provisional registration problem?

The ‘ART’ of Scottish community pharmacy is all about data

I failed by one mark and now can’t register as a pharmacist

Pharmacists should not have to bend the rules

More letters to the editor here...

Blogs

💊 PIP live pharmacy blog

Winter stresses must not ‘destabilise’ general practice

What is it like to depend on medicine to treat endometriosis?

Opinion

Why is pharmacy not integral to government mass vaccination plans?

Pharmacy Covid-19 vaccination involvement is a ‘no-brainer’

The great patient medication returns debacle

CPD Challenges

💊 CPD Challenge: How well do you understand pulmonary embolisms?

💊 CPD Challenge: Prescribing and dispensing clozapine

💊 CPD Challenge: Oral anticoagulants – Dabigatran

More CPD challenges here...

© 2021 · About Pharmacy In Practice · Site mantained by Mike

This site is for healthcare professionals, please confirm you are a healthcare professional to continue.

YES

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
Pharmacy In Practice uses cookies, by continuing to use this site we will assume you are ok with that Find out more.